LeMaitre Vascular: The Compounder Keeps Compounding
Source: SeekingAlpha
2026-02-27 15:01:26 ET
I last covered LeMaitre Vascular (NASDAQ:LMAT) at $81 in June 2025 , reiterating my Buy rating. Eight months later, shares are up about 35%, more than double that of the broader market. The stock jumped ~20% alone on the recent Q4 beat and raise, with 2026 guidance coming in 13% above Wall Street’s consensus. Pricing power, operating leverage, and international growth were all contributors....
Read the full article on Seeking Alpha
For further details see:
LeMaitre Vascular: The Compounder Keeps Compounding
Medtronic plc.
NASDAQ: MDT
MDT Trading
-1.36% G/L:
$89.11 Last:
3,300,055 Volume:
$90 Open:
MDT Latest News
March 10, 2026 06:45:00 am
Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care
MDT Stock Data
$130,938,521,134
1,269,194,066
0.03%
8
N/A
Medical Equipment & Supplies
Healthcare
IE
Galway
